Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Scheja

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Clinical and Experimental Rheumatology|July 10, 2002
The association between changes in skin echogenicity and the fibroblast production of biglycan and versican in systemic sclerosisR Hesselstrand, G Westergren-Thorsson, A Scheja, et al.
Scandinavian Journal of Rheumatology|October 6, 2010
Enlarged right-sided dimensions and fibrosis of the right ventricular insertion point on cardiovascular magnetic resonance imaging is seen early in patients with pulmonary arterial hypertension associated with connective tissue diseaseR Hesselstrand, A Scheja, D M Wuttge, et al.
Rheumatology (Oxford, England)|October 18, 2000
Circulating collagen metabolites in systemic sclerosis. Differences between limited and diffuse form and relationship with pulmonary involvementA Scheja, M Wildt, F A Wollheim, et al.
Scandinavian Journal of Rheumatology|September 23, 2010
Survival in patients with pulmonary arterial hypertension associated with systemic sclerosis from a Swedish single centre: prognosis still poor and prediction difficultR Hesselstrand, M Wildt, B Ekmehag, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1995
Esophageal scintigraphy of systemic sclerosisL Edenbrandt, E Theander, M Högström, et al.
Annals of the Rheumatic Diseases|January 1, 1996
Computer based quantitative analysis of capillary abnormalities in systemic sclerosis and its relation to plasma concentration of von Willebrand factorA Scheja, A Akesson, I Niewierowicz, et al.
Scandinavian Journal of Rheumatology|January 1, 1992
Long-term evaluation of penicillamine or cyclofenil in systemic sclerosis. Results from a two-year randomized studyA Akesson, B Blom-Bülow, A Scheja, et al.
Clinical and Experimental Rheumatology|November 6, 2010
Increased alveolar nitric oxide in early systemic sclerosisD M Wuttge, G Bozovic, R Hesselstrand, et al.
Rheumatology (Oxford, England)|November 25, 2004
Screening for pulmonary hypertension in systemic sclerosis: the longitudinal development of tricuspid gradient in 227 consecutive patients, 1992-2001R Hesselstrand, R Ekman, J Eskilsson, et al.
Scandinavian Journal of Rheumatology|February 6, 2013
Increased serum type I interferon activity in early systemic sclerosis patients is associated with antibodies against Sjögren's syndrome antigens and nuclear ribonucleoprotein antigensD M Wuttge, C Lood, E Tufvesson, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Clinical and Experimental Rheumatology|July 10, 2002
The association between changes in skin echogenicity and the fibroblast production of biglycan and versican in systemic sclerosisR Hesselstrand, G Westergren-Thorsson, A Scheja, et al.
Scandinavian Journal of Rheumatology|October 6, 2010
Enlarged right-sided dimensions and fibrosis of the right ventricular insertion point on cardiovascular magnetic resonance imaging is seen early in patients with pulmonary arterial hypertension associated with connective tissue diseaseR Hesselstrand, A Scheja, D M Wuttge, et al.
Rheumatology (Oxford, England)|October 18, 2000
Circulating collagen metabolites in systemic sclerosis. Differences between limited and diffuse form and relationship with pulmonary involvementA Scheja, M Wildt, F A Wollheim, et al.
Scandinavian Journal of Rheumatology|September 23, 2010
Survival in patients with pulmonary arterial hypertension associated with systemic sclerosis from a Swedish single centre: prognosis still poor and prediction difficultR Hesselstrand, M Wildt, B Ekmehag, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1995
Esophageal scintigraphy of systemic sclerosisL Edenbrandt, E Theander, M Högström, et al.
Annals of the Rheumatic Diseases|January 1, 1996
Computer based quantitative analysis of capillary abnormalities in systemic sclerosis and its relation to plasma concentration of von Willebrand factorA Scheja, A Akesson, I Niewierowicz, et al.
Scandinavian Journal of Rheumatology|January 1, 1992
Long-term evaluation of penicillamine or cyclofenil in systemic sclerosis. Results from a two-year randomized studyA Akesson, B Blom-Bülow, A Scheja, et al.
Clinical and Experimental Rheumatology|November 6, 2010
Increased alveolar nitric oxide in early systemic sclerosisD M Wuttge, G Bozovic, R Hesselstrand, et al.
Rheumatology (Oxford, England)|November 25, 2004
Screening for pulmonary hypertension in systemic sclerosis: the longitudinal development of tricuspid gradient in 227 consecutive patients, 1992-2001R Hesselstrand, R Ekman, J Eskilsson, et al.
Scandinavian Journal of Rheumatology|February 6, 2013
Increased serum type I interferon activity in early systemic sclerosis patients is associated with antibodies against Sjögren's syndrome antigens and nuclear ribonucleoprotein antigensD M Wuttge, C Lood, E Tufvesson, et al.
Pageof 5